Related Experiment Video

Updated: Apr 4, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.8K

Mechanical aberrations in hypetrophic cardiomyopathy: emerging concepts

Dimitrios Ntelios1, Georgios Tzimagiorgis2, Georgios K Efthimiadis3

  • 1Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki Thessaloniki, Greece ; Department of Cardiology, AHEPA University Hospital Thessaloniki, Greece.

Frontiers in Physiology
|September 9, 2015
PubMed

Insights

Hypertrophic cardiomyopathy, a genetic heart condition, arises from sarcomere defects. This analysis explores how these flaws impact cardiac mechanics and disease presentation.

Area of Science:

  • Cardiology
  • Genetics
  • Biophysics

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic cardiac disorder.
  • Current understanding of HCM pathogenesis has not fully elucidated the link between sarcomere component defects and clinical phenotype.
  • Sarcomere dysfunction is a key feature in HCM, but specific mechanisms remain unclear.

Purpose of the Study:

  • To analyze proposed pathophysiological mechanisms of hypertrophic cardiomyopathy.
  • To emphasize the role of altered cardiac mechanical properties in HCM.
  • To provide an interpretative overview of HCM disease mechanisms.

Main Methods:

  • Literature review and interpretative analysis.
  • Focus on current pathophysiological hypotheses.
  • Emphasis on alterations in cardiac mechanical properties.

Main Results:

  • Defects in individual sarcomere proteins contribute to HCM.
  • Altered cardiac mechanical properties are central to HCM pathogenesis.
  • Specific sarcomere flaws lead to abnormal myocardial function.

Conclusions:

  • Understanding sarcomere mechanics is crucial for HCM.
  • Further research into sarcomere protein function is needed.
  • Targeting mechanical alterations may offer therapeutic strategies for HCM.

Keywords:
LVOT obstructioncardiac mechanicsepicardial-endocardial synergyhypertrophic cardiomyopathymyocardial disarraystretch activation

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
824
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
656
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
945
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772